Literature DB >> 18773305

Induced apoptotic action of recombinant trichosanthin in human stomach adenocarcinoma MCG803 cells.

Jun Xu1, De-Fu Gao, Guo-Li Yan, Jian-Ming Fan.   

Abstract

Trichosanthin (TCS), is purified from the Chinese medicine, exerts antitumor activities by inducing apoptosis in many different tumor cell lines. The cDNA of trichosanthin was cloned and TCS was purified. The results showed that the proliferation of MCG803 cells were significantly suppressed by TCS in a dose-dependent manner at the concentration ranging from 20 to 100 microg/ml. The result of sequencing analysis indicates we obtained the TCS whole length gene. MTT assay was adopted to measure the growth inhibition ratio of MCG803 cells treated with TCS and apoptosis was assayed by agarose gel electrophoresis. DNA agarose gel electrophoresis showed a gradient, which confirmed that TCS could induce MCG803 cells apoptosis. The proportion of the periodic tumor cells were altered by TCS. Sub-G(1) curves were displayed by flow cytometry analysis. Results of Northern and Western blots showed that the transcription and expression of P21, was gradually up-regulated as treatment time increased. On the contrary, the transcription and expression of p53, was down-regulated. These data provided powerful evidences for the first time that recombinant TCS can induce the apoptosis of the MCG803 cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18773305     DOI: 10.1007/s11033-008-9352-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  19 in total

1.  Trichosanthin interacts with acidic ribosomal proteins P0 and P1 and mitotic checkpoint protein MAD2B.

Authors:  S H Chan; F S Hung; D S Chan; P C Shaw
Journal:  Eur J Biochem       Date:  2001-04

2.  Capillary electrophoretic determination of apoptosis of HeLa cells induced by trichosanthin.

Authors:  Q H Ru; G A Luo; J J Liao; Y Liu
Journal:  J Chromatogr A       Date:  2000-10-13       Impact factor: 4.759

3.  Receptor-mediated endocytosis of trichosanthin in choriocarcinoma cells.

Authors:  Wood Yee Chan; Hai Huang; Siu-Cheung Tam
Journal:  Toxicology       Date:  2003-04-22       Impact factor: 4.221

Review 4.  Recent advances in trichosanthin, a ribosome-inactivating protein with multiple pharmacological properties.

Authors:  Pang-Chui Shaw; Ka-Ming Lee; Kam-Bo Wong
Journal:  Toxicon       Date:  2005-05       Impact factor: 3.033

5.  Engineering of a mini-trichosanthin that has lower antigenicity by deleting its C-terminal amino acid residues.

Authors:  S H Chan; P C Shaw; S F Mulot; L H Xu; W L Chan; S C Tam; K B Wong
Journal:  Biochem Biophys Res Commun       Date:  2000-04-02       Impact factor: 3.575

6.  Enhanced apoptotic action of trichosanthin in HIV-1 infected cells.

Authors:  Yuan-Yuan Wang; Dong-Yun Ouyang; Hai Huang; Herman Chan; Siu-Cheung Tam; Yong-Tang Zheng
Journal:  Biochem Biophys Res Commun       Date:  2005-06-17       Impact factor: 3.575

7.  Trichosanthin induced apoptosis in HL-60 cells via mitochondrial and endoplasmic reticulum stress signaling pathways.

Authors:  Jie Li; Xuechun Xia; Yibao Ke; Huiling Nie; Mark A Smith; Xiongwei Zhu
Journal:  Biochim Biophys Acta       Date:  2007-05-03

Review 8.  Bcl-2-targeted antisense therapy (Oblimersen sodium): towards clinical reality.

Authors:  João Nuno Moreira; Adriana Santos; Sérgio Simões
Journal:  Rev Recent Clin Trials       Date:  2006-09

9.  The structural basis of Trp192 and the C-terminal region in trichosanthin for activity and conformational stability.

Authors:  Yi Ding; Hiumei Too; Zhilong Wang; Yiwei Liu; Mark Bartlam; Yicheng Dong; Kambo Wong; Pangchui Shaw; Zihe Rao
Journal:  Protein Eng       Date:  2003-05

10.  Identification of the amino acid residues in trichosanthin crucial for IgE response.

Authors:  Xuan Cai; Gang Yao; Guofeng Xu; Cuihong Yang; Hong Xu; Ying Lin; Jian Yu; Bing Sun
Journal:  Biochem Biophys Res Commun       Date:  2002-09-27       Impact factor: 3.575

View more
  8 in total

1.  Downregulation of ornithine decarboxylase by pcDNA-ODCr inhibits gastric cancer cell growth in vitro.

Authors:  Chun-xiao Xu; Yun-fei Yan; Ya-pei Yang; Bin Liu; Jia-xuan Xin; Shi-min Chen; Wei Wang; Chun-ying Jiang; Zhao-xin Lu; Xian-xi Liu
Journal:  Mol Biol Rep       Date:  2010-06-09       Impact factor: 2.316

2.  Influence of sCD40L on gastric cancer cell lines.

Authors:  Rui Li; Wei-Chang Chen; Xue-Qin Pang; Wen-Yan Tian; Xue-Guang Zhang
Journal:  Mol Biol Rep       Date:  2011-03-20       Impact factor: 2.316

3.  Experimental investigation of the immunoregulatory and anti-inflammatory effects of the traditional Chinese medicine "Li-Yan Zhi-Ke Granule" for relieving chronic pharyngitis in rats.

Authors:  Yiyi Sun; Zhihe Zang; Xiaohong Xu; Zhonglin Zhang; Ling Zhong; Wang Zan; Yan Zhao; Lin Sun
Journal:  Mol Biol Rep       Date:  2010-03-28       Impact factor: 2.316

Review 4.  Advances on Tumor-Targeting Delivery of Cytotoxic Proteins.

Authors:  Akmal M Asrorov; Zeyun Gu; Kyoung Ah Min; Meong Cheol Shin; Yongzhuo Huang
Journal:  ACS Pharmacol Transl Sci       Date:  2019-12-30

Review 5.  Anti-tumor activities and apoptotic mechanism of ribosome-inactivating proteins.

Authors:  Meiqi Zeng; Manyin Zheng; Desheng Lu; Jun Wang; Wenqi Jiang; Ou Sha
Journal:  Chin J Cancer       Date:  2015-07-17

Review 6.  Structural and Functional Investigation and Pharmacological Mechanism of Trichosanthin, a Type 1 Ribosome-Inactivating Protein.

Authors:  Wei-Wei Shi; Kam-Bo Wong; Pang-Chui Shaw
Journal:  Toxins (Basel)       Date:  2018-08-20       Impact factor: 4.546

Review 7.  Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents.

Authors:  Akmal M Asrorov; Bahtiyor Muhitdinov; Bin Tu; Sharafitdin Mirzaakhmedov; Huiyuan Wang; Yongzhuo Huang
Journal:  Molecules       Date:  2022-06-14       Impact factor: 4.927

Review 8.  Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review.

Authors:  Ou Sha; Junfei Niu; Tzi-Bun Ng; Eric Yu-Pang Cho; Xiaoyuan Fu; Wenqi Jiang
Journal:  Cancer Chemother Pharmacol       Date:  2013-02-03       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.